Takeda sales and marketing update

Takeda launched once-weekly oral Zafatek trelagliptin in Japan to treat Type II diabetes. The Japanese National Health Insurance (NHI) list price of the dipeptidyl peptidase-4 (DPP-4) inhibitor is Y...